1 |
0.02% fm, sh, as |
- |
- |
- |
- |
053 1件: 53 💬 |
2 |
1500mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
3 |
250mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
4 |
2l polyethylene glycol/ascorbic acid |
Ascorbic acid |
2件: D00018 D00018, D03370 D03370 💬 |
- |
- |
097 1件: 97 💬 |
5 |
5 asa, enemas, suppositories, corticosteroids |
- |
- |
- |
- |
097 1件: 97 💬 |
6 |
5-amino salicylic acid (5-asa) |
Mesalazine |
2件: D00097 D00097, D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
7 |
5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
8 |
5-aminosalicylic acid(5-asa) and/or prednisone |
Aminosalicylic acid |
3件: D00162 D00162, D00377 D00377, D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
9 |
5-asa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 2件: 96, 97 💬 |
10 |
5-asa (5-aminosalicylate) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
11 |
5-asa mmx |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
12 |
500mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
13 |
750mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
14 |
81mg aspirin |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
049 1件: 49 💬 |
15 |
A novel synthetic, orally-administered, non-peptide small molecule, which acts as |
- |
- |
- |
- |
254 1件: 254 💬 |
16 |
Acetylsalicylic acid |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 4件: 13, 46, 51, 210 💬 |
17 |
Acetylsalicylic acid at 1st visit, |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
18 |
Achim as solute (10^9 intestinal microbes/ml) |
- |
- |
- |
- |
051 1件: 51 💬 |
19 |
Acido ascorbico |
- |
- |
- |
- |
010 1件: 10 💬 |
20 |
Acido ascorbico dc.it |
- |
- |
- |
- |
010 1件: 10 💬 |
21 |
Acidum ascorbicum |
Ascorbic acid |
1件: D00018 D00018 💬 |
- |
- |
206 1件: 206 💬 |
22 |
Acidum ascorbicum d6 |
Ascorbic acid |
1件: D00018 D00018 💬 |
- |
- |
206 1件: 206 💬 |
23 |
Acr16 hydrochloride, asp2314 hydrochloride, fr310826 |
- |
- |
- |
- |
008 1件: 8 💬 |
24 |
Adeno-associated viral (aav) serotype 8 (aav2/8) vector with liver-specific thyroxine-binding globulin (tbg) promoter, driving the expression of the human arsb gene |
Levothyroxine |
2件: D01010 D01010, D08125 D08125 💬 |
THRA 2件: THRA, THRB 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
019 1件: 19 💬 |
25 |
Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene |
- |
- |
- |
- |
113 1件: 113 💬 |
26 |
Adeno-associated viral vector serotype 9 containing the human n-acetyl-alpha-glucosaminidase gene |
- |
- |
- |
- |
019 1件: 19 💬 |
27 |
Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase a cdna |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
28 |
Adeno-associated virus serotype 2/6 encoding human iduronate 2-sulfatase (hids) gene donor vector, sb-a6p-hnt donor vector |
Idursulfase |
1件: D04499 D04499 💬 |
IDS 1件: IDS 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |
29 |
Adeno-associated virus serotype 2/6 encoding human iduronidase (hidua) gene donor vector, sb-a6p-hrl donor vector |
- |
- |
- |
- |
019 1件: 19 💬 |
30 |
Adeno-associated virus serotype 2/6 encoding left side-zinc finger nuclease (zfn1), sb-a6p-zleft vector |
- |
- |
- |
- |
019 1件: 19 💬 |
31 |
Adeno-associated virus serotype 2/6 encoding right side-zinc finger nuclease (zfn2), sb-a6p-zright vector |
- |
- |
- |
- |
019 1件: 19 💬 |
32 |
Adeno-associated virus-cftr vector |
- |
- |
- |
- |
299 1件: 299 💬 |
33 |
Allo-asc |
- |
- |
- |
- |
096 1件: 96 💬 |
34 |
Allo-asc-cd |
- |
- |
- |
- |
096 1件: 96 💬 |
35 |
Allo-asc-dfu |
- |
- |
- |
- |
036 1件: 36 💬 |
36 |
Aln-as1 |
- |
- |
- |
- |
254 1件: 254 💬 |
37 |
Amoxapine |
Amoxapine |
1件: D00228 D00228 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
046 1件: 46 💬 |
38 |
Amoxapine & dipyridamole |
Amoxapine |
2件: D00228 D00228, D00302 D00302 💬 |
PDE4A 4件: PDE4A, PDE5A, SLC6A2, SLC6A4 💬 |
Metabolic pathways 8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
39 |
As |
- |
- |
- |
- |
046 6件: 46, 53, 96, 97, 215, 271 💬 |
40 |
As inn |
- |
- |
- |
- |
097 1件: 97 💬 |
41 |
As2 |
- |
- |
- |
- |
006 1件: 6 💬 |
42 |
Asa |
- |
- |
- |
- |
013 4件: 13, 96, 97, 251 💬 |
43 |
Asacol |
- |
- |
- |
- |
097 1件: 97 💬 |
44 |
Asacol (mesalamine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
45 |
Asacol (mesalamine) delayed-release tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
46 |
Asacol 400 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
47 |
Asacol 400 mg (mesalamine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
48 |
Asacol 400 mg tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
49 |
Asacol 400mg tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
50 |
Asacol 800 mg (mesalamine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
51 |
Asacol 800 mg tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
52 |
Asacol 800mg tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
53 |
Asacol delayed release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
54 |
Asacol delayed-release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
55 |
Asacol tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
56 |
Asacol® |
- |
- |
- |
- |
097 1件: 97 💬 |
57 |
Asacol® 400 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
58 |
Asasantin retard |
- |
- |
- |
- |
051 1件: 51 💬 |
59 |
Asasantin retard ® |
- |
- |
- |
- |
051 1件: 51 💬 |
60 |
Asb-683699 |
- |
- |
- |
- |
013 1件: 13 💬 |
61 |
Asc |
- |
- |
- |
- |
036 4件: 36, 51, 96, 97 💬 |
62 |
Ascal(r) / carbasalate calcium |
Calcium |
1件: D03385 D03385 💬 |
- |
- |
046 1件: 46 💬 |
63 |
Ascorbic acid |
Ascorbic acid |
1件: D00018 D00018 💬 |
- |
- |
010 4件: 10, 97, 206, 298 💬 |
64 |
Ascorbic acid (vitamin c) |
Ascorbic acid |
1件: D00018 D00018 💬 |
- |
- |
010 1件: 10 💬 |
65 |
Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e) |
Ascorbic acid |
3件: D00018 D00018, D02331 D02331, D02332 D02332 💬 |
- |
- |
206 1件: 206 💬 |
66 |
Ascorbic acid vit c |
Ascorbic acid |
1件: D00018 D00018 💬 |
- |
- |
010 1件: 10 💬 |
67 |
Ascs |
- |
- |
- |
- |
053 2件: 53, 96 💬 |
68 |
Ascs: adipose derived stem cells |
- |
- |
- |
- |
096 1件: 96 💬 |
69 |
Asendis |
- |
- |
- |
- |
046 1件: 46 💬 |
70 |
Asendis 50 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
71 |
Asf-1096 cream 0.25% |
- |
- |
- |
- |
049 1件: 49 💬 |
72 |
Asf-1096 cream 0.5% |
- |
- |
- |
- |
049 1件: 49 💬 |
73 |
Asf-1096 cream 1.0% |
- |
- |
- |
- |
049 1件: 49 💬 |
74 |
Asfotas alfa |
- |
- |
- |
- |
172 1件: 172 💬 |
75 |
Asfotase alfa |
Asfotase alfa |
1件: D10595 D10595 💬 |
ALPL 1件: ALPL 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism |
172 1件: 172 💬 |
76 |
Asfotase alfa (alxn1215) |
Asfotase alfa |
1件: D10595 D10595 💬 |
ALPL 1件: ALPL 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism |
172 1件: 172 💬 |
77 |
Ask nr. 21972 |
- |
- |
- |
- |
005 1件: 5 💬 |
78 |
Ask8007 |
- |
- |
- |
- |
046 1件: 46 💬 |
79 |
Asp015k |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
80 |
Asp015k hydrobromide |
- |
- |
- |
- |
046 1件: 46 💬 |
81 |
Asp015k hydrobromide, as1940150-br, jkt-201a, 4-{[(1r,2s,3s,5s,7s)-5-hydroxy-2-adamantyl]amino}-1h-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide |
- |
- |
- |
- |
046 1件: 46 💬 |
82 |
Asp0367 |
- |
- |
- |
- |
113 1件: 113 💬 |
83 |
Asp1707 |
- |
- |
- |
- |
046 1件: 46 💬 |
84 |
Asp2408 |
- |
- |
- |
- |
046 1件: 46 💬 |
85 |
Asp2409 |
- |
- |
- |
- |
046 1件: 46 💬 |
86 |
Asp3291 |
- |
- |
- |
- |
097 1件: 97 💬 |
87 |
Asp3652 |
- |
- |
- |
- |
226 1件: 226 💬 |
88 |
Asp5094 |
- |
- |
- |
- |
046 1件: 46 💬 |
89 |
Asp6294 |
- |
- |
- |
- |
226 1件: 226 💬 |
90 |
Aspergillus oryzae |
Aspergillus oryzae |
- |
- |
- |
097 1件: 97 💬 |
91 |
Aspirin |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 11件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
92 |
Aspirin 650mg oral capsule |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
93 |
Aspirin 81mg tablet |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
94 |
Aspirin and meloxicam |
Acetylsalicylic acid |
2件: D00109 D00109, D00969 D00969 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
049 1件: 49 💬 |
95 |
Aspirin tablets |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
96 |
Assigned pulmonary hypertension medication |
- |
- |
- |
- |
086 1件: 86 💬 |
97 |
Ast-120 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
98 |
Astrorx |
- |
- |
- |
- |
002 1件: 2 💬 |
99 |
Asyn mab |
- |
- |
- |
- |
006 1件: 6 💬 |
100 |
Autologous asc |
- |
- |
- |
- |
051 1件: 51 💬 |
101 |
Avxs-101 (previously known as scaav9.cb.smn) |
- |
- |
- |
- |
003 1件: 3 💬 |
102 |
Azathioprine or mesalazine |
Azathioprine |
3件: D00238 D00238, D00377 D00377, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
103 |
B2-asmedic |
- |
- |
- |
- |
097 1件: 97 💬 |
104 |
Behavioral: assessment of cognition |
- |
- |
- |
- |
006 1件: 6 💬 |
105 |
Behavioral: assessment of depression |
- |
- |
- |
- |
006 1件: 6 💬 |
106 |
Behavioral: assessment of disability |
- |
- |
- |
- |
013 1件: 13 💬 |
107 |
Behavioral: assessment of impact of ms on cognition |
- |
- |
- |
- |
013 1件: 13 💬 |
108 |
Behavioral: assessment of motor and non-motors symptoms of pd evaluation of hyper- and hypodopaminergic behaviors |
- |
- |
- |
- |
006 1件: 6 💬 |
109 |
Behavioral: assessment of quality of life |
- |
- |
- |
- |
006 1件: 6 💬 |
110 |
Behavioral: assessment of severity of icd (impulse control disorders) |
- |
- |
- |
- |
006 1件: 6 💬 |
111 |
Behavioral: assessment of severity of parkinson disease |
- |
- |
- |
- |
006 1件: 6 💬 |
112 |
Behavioral: emotion assessment |
- |
- |
- |
- |
006 1件: 6 💬 |
113 |
Behavioral: montreal cognitive assessment (moca) |
- |
- |
- |
- |
017 1件: 17 💬 |
114 |
Behavioral: neuro-psychological assessment |
- |
- |
- |
- |
240 1件: 240 💬 |
115 |
Behavioral: participant self-assessment surveys |
- |
- |
- |
- |
006 1件: 6 💬 |
116 |
Behavioral: physical exam and updrs part iii assessment |
- |
- |
- |
- |
006 1件: 6 💬 |
117 |
Behavioral: quality of life assessment |
- |
- |
- |
- |
081 1件: 81 💬 |
118 |
Behavioral: smoking and alcohol assumption |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
298 1件: 298 💬 |
119 |
Bgj398 (also known as bbp-831) |
- |
- |
- |
- |
276 1件: 276 💬 |
120 |
Bio-enhanced curcumin soft gelatin capsule |
Curcumin |
2件: D00115 D00115, D06892 D06892 💬 |
- |
- |
097 1件: 97 💬 |
121 |
Biological assays |
- |
- |
- |
- |
019 1件: 19 💬 |
122 |
Blood draw for the laboratory assessment |
- |
- |
- |
- |
303 1件: 303 💬 |
123 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
14件: D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A 15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
124 |
Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf |
Busulfan |
8件: D00107 D00107, D00142 D00142, D00248 D00248, D01907 D01907, D02115 D02115, D03235 D03235, D07966 D07966, D08556 D08556 💬 |
CSF3R 9件: CSF3R, DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 |
Alzheimer disease 46件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
125 |
Care as usual |
- |
- |
- |
- |
015 1件: 15 💬 |
126 |
Cbd - oral solution, is known as epidiolex, and is the approved name in the usa. |
- |
- |
- |
- |
140 3件: 140, 144, 158 💬 |
127 |
Cbd - oral solution, is known as epidyolex, and is the approved name |
- |
- |
- |
- |
156 1件: 156 💬 |
128 |
Cbd oral solution, is known as epidyolex and is the approved name in the eu |
- |
- |
- |
- |
156 1件: 156 💬 |
129 |
Cbd-oral solution, is known as epidiolex, and is the approved name in the usa. |
- |
- |
- |
- |
158 1件: 158 💬 |
130 |
Cere-120 (adeno-associated virus serotype 2 [aav2]-neurturin [ntn]) |
- |
- |
- |
- |
006 1件: 6 💬 |
131 |
Cere-120: adeno-associated virus delivery of neurturin |
- |
- |
- |
- |
006 1件: 6 💬 |
132 |
Clarithromycin (not used as of 4/2020) |
Clarithromycin |
1件: D00276 D00276 💬 |
- |
- |
006 1件: 6 💬 |
133 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d) trp-ly di-aspartate |
- |
- |
- |
- |
075 1件: 75 💬 |
134 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d)trp-ly di-aspartate |
- |
- |
- |
- |
075 1件: 75 💬 |
135 |
Cyclo((diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) di-aspartate |
- |
- |
- |
- |
075 1件: 75 💬 |
136 |
D-aspartate |
- |
- |
- |
- |
013 1件: 13 💬 |
137 |
Delayed and extended release mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
138 |
Device: as domelock system |
- |
- |
- |
- |
046 1件: 46 💬 |
139 |
Device: measurment with aspirational medical device |
- |
- |
- |
- |
051 1件: 51 💬 |
140 |
Device: paired associative stimulation (pas) |
- |
- |
- |
- |
013 1件: 13 💬 |
141 |
Device: sleep assessment |
- |
- |
- |
- |
013 1件: 13 💬 |
142 |
Device: use of bioanalytical assay to monitor plasma levels of perhexiline |
Methamidophos |
2件: D05442 D05442, D08340 D08340 💬 |
CACNA1C 8件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬 |
AMPK signaling pathway 45件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
058 1件: 58 💬 |
143 |
Diagnostic test: audiology assessmentwith abr |
- |
- |
- |
- |
019 1件: 19 💬 |
144 |
Diagnostic test: auto-assessment manikins (sam) |
- |
- |
- |
- |
006 1件: 6 💬 |
145 |
Diagnostic test: frontal assessment battery (fab) |
- |
- |
- |
- |
006 1件: 6 💬 |
146 |
Diagnostic test: hearing assessment |
- |
- |
- |
- |
122 1件: 122 💬 |
147 |
Diagnostic test: neuropsychological assessment |
- |
- |
- |
- |
006 2件: 6 , 127 💬 |
148 |
Diagnostic test: scale for assessment and rating of ataxia |
- |
- |
- |
- |
113 1件: 113 💬 |
149 |
Diagnostic test: supplementary neuropsychological assessment - parkinson's disease |
- |
- |
- |
- |
006 2件: 6 , 127 💬 |
150 |
Diagnostic test: vestibular/balance assessment |
Isoxaflutole |
- |
- |
- |
122 1件: 122 💬 |
151 |
Dipyridamole and amoxapine |
Amoxapine |
2件: D00228 D00228, D00302 D00302 💬 |
PDE4A 4件: PDE4A, PDE5A, SLC6A2, SLC6A4 💬 |
Metabolic pathways 8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
152 |
Egcg as putative neuroprotective agent |
Epigallocatechin gallate |
- |
- |
- |
017 1件: 17 💬 |
153 |
Epinephrine |
Epinephrine |
3件: D00095 D00095, D00996 D00996, D02149 D02149 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 2件: 46, 96 💬 |
154 |
Era as specific pah treatment |
- |
- |
- |
- |
086 1件: 86 💬 |
155 |
Extended release dipyridamole 200mg/aspirin 25mg |
Acetylsalicylic acid |
2件: D00109 D00109, D00302 D00302 💬 |
PDE4A 4件: PDE4A, PDE5A, PTGS1, PTGS2 💬 |
Alzheimer disease 28件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Purine metabolism, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 1件: 49 💬 |
156 |
Fludrocortisone |
Fludrocortisone |
2件: D00986 D00986, D07967 D07967 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
006 3件: 6 , 17, 81 💬 |
157 |
Gelatin |
Gelatin |
2件: D00115 D00115, D06892 D06892 💬 |
- |
- |
028 4件: 28, 78, 97, 269 💬 |
158 |
Genetic: optional pharmacogenetic assessment |
- |
- |
- |
- |
006 1件: 6 💬 |
159 |
Genetic: recombinant adeno-associated virus acid alpha-glucosidase |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
160 |
Givosiran (aln-as1) |
Givosiran |
1件: D11702 D11702 💬 |
ALAS1 1件: ALAS1 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
254 1件: 254 💬 |
161 |
Glutamate and aspartate |
- |
- |
- |
- |
013 1件: 13 💬 |
162 |
High dose aspirin (1300 mg/day) |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
163 |
Hm71224 multiple ascending dose |
- |
- |
- |
- |
046 1件: 46 💬 |
164 |
Hm71224 single ascending dose |
- |
- |
- |
- |
046 1件: 46 💬 |
165 |
Homeostasis model assessment of insulin resistance (homa) |
- |
- |
- |
- |
017 1件: 17 💬 |
166 |
Human albumin as macroaggregates |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
096 1件: 96 💬 |
167 |
Human coagulation factor viii associated with von willebrand factor (vwf) |
Antihemophilic factor human |
- |
- |
- |
288 1件: 288 💬 |
168 |
Imp will be labeled as ''pf-04236921 106mg/vial, clonal sc lyophilized form''. |
- |
- |
- |
- |
096 1件: 96 💬 |
169 |
Imp will be labeled as pf-04236921 106mg/vial, clonal sc lyophilized form |
- |
- |
- |
- |
096 1件: 96 💬 |
170 |
Insulin asparte |
- |
- |
- |
- |
299 1件: 299 💬 |
171 |
Interferon beta-1b and tacrolimus |
Human interferon beta |
3件: D00107 D00107, D00746 D00746, D08556 D08556 💬 |
IFNAR1 7件: IFNAR1, IFNAR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 47件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
172 |
Intraarticular morphine |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
173 |
Lap tap bupivacaine/epinephrine |
Bupivacaine |
5件: D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A 14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
174 |
Lcp-tacro (tacrolimus) |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
095 1件: 95 💬 |
175 |
Low dose aspirin (162 mg/day) |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
176 |
Magnesium aspartate |
Magnesium |
1件: D02026 D02026 💬 |
- |
- |
298 1件: 298 💬 |
177 |
Magnesium aspartate hydrochloride |
Magnesium |
1件: D02026 D02026 💬 |
- |
- |
298 1件: 298 💬 |
178 |
Mesalamine, 5-aminosalicylic acid [5-asa] |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
179 |
Mesalamine, 5-asa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
180 |
Mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
046 3件: 46, 96, 97 💬 |
181 |
Mesalazine (3,600 mg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
182 |
Mesalazine (asacol®) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
183 |
Mesalazine (mesalamine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
184 |
Mesalazine - tid 1000 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
185 |
Mesalazine - tid 2x 500 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
186 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
187 |
Mesalazine 250mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
188 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
2件: D00377 D00377, D02486 D02486 💬 |
- |
- |
097 1件: 97 💬 |
189 |
Mesalazine 4g enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
190 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
191 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
192 |
Mesalazine ec 500 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
193 |
Mesalazine enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
194 |
Mesalazine liquid enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
195 |
Mesalazine slow-release granules |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
196 |
Mesalazine sustained-release tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
197 |
Mesalazine tablet |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
198 |
Mesalazine tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
199 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
2件: D00088 D00088, D00377 D00377 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
200 |
Mesalazine, tripterygium glycosides |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
201 |
Methotrexate as methotrexate disodium |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
202 |
Mmx mesalamine/ mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
203 |
Mmx mesalamine/mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
204 |
Mmx mesalamine/mesalazine (high dose) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
205 |
Mmx mesalamine/mesalazine (low dose) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
206 |
Mometasone |
Mometasone |
3件: D00690 D00690, D03325 D03325, D08227 D08227 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 2件: 98, 162 💬 |
207 |
Mometasone furoate |
Mometasone |
3件: D00690 D00690, D03325 D03325, D08227 D08227 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 2件: 98, 162 💬 |
208 |
Morphine |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 5件: 36, 46, 70, 85, 86 💬 |
209 |
Morphine hexal |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
210 |
Morphine hydrochloride |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
085 1件: 85 💬 |
211 |
Morphine pca |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
212 |
Morphine sulfate |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 3件: 46, 85, 86 💬 |
213 |
Morphine sulphate in intrasite gel |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 1件: 36 💬 |
214 |
Msc2430913a or ono-4641 (to be used as synonyms) |
- |
- |
- |
- |
013 1件: 13 💬 |
215 |
Neo-asa |
- |
- |
- |
- |
251 1件: 251 💬 |
216 |
Neoral soft gelatin capsules |
Gelatin |
2件: D00115 D00115, D06892 D06892 💬 |
- |
- |
097 2件: 97, 269 💬 |
217 |
Non as of yet |
- |
- |
- |
- |
097 1件: 97 💬 |
218 |
None as of yet |
- |
- |
- |
- |
046 1件: 46 💬 |
219 |
None assigned |
- |
- |
- |
- |
231 2件: 231, 299 💬 |
220 |
Novorapid aspartate |
- |
- |
- |
- |
299 1件: 299 💬 |
221 |
Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone |
Mesalazine |
7件: D00377 D00377, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
222 |
Other: 5-asa withdrawal |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
223 |
Other: assessment of medication compliance |
- |
- |
- |
- |
098 1件: 98 💬 |
224 |
Other: eating assessment tool 10 |
- |
- |
- |
- |
002 1件: 2 💬 |
225 |
Other: eating assessment tool-10 |
- |
- |
- |
- |
002 1件: 2 💬 |
226 |
Other: mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
227 |
Other: monthly assessments of functional motor abilities by a trained therapist |
- |
- |
- |
- |
003 1件: 3 💬 |
228 |
Other: motor assessments before taking regular pd treatment |
- |
- |
- |
- |
006 1件: 6 💬 |
229 |
Other: motor assessments on regular pd treatment |
- |
- |
- |
- |
006 1件: 6 💬 |
230 |
Other: observation of ocrelizumab as treatment in rrms patients |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
231 |
Other: oral glucose tolerance test (ogtt) assessment arm |
Dextrose, unspecified form |
- |
- |
- |
299 1件: 299 💬 |
232 |
Other: pentasa (mesalamine/ 5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
233 |
Other: quality of life assessment |
- |
- |
- |
- |
122 1件: 122 💬 |
234 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 5件: 34, 36, 51, 96, 298 💬 |
235 |
Other: rp% measurement by fcm as a diagnostic test for itp |
- |
- |
- |
- |
063 1件: 63 💬 |
236 |
Other: saline as a nasal spray |
- |
- |
- |
- |
226 1件: 226 💬 |
237 |
Other: ultrasonography assessment |
- |
- |
- |
- |
049 1件: 49 💬 |
238 |
Other: vasculopathy assessment |
- |
- |
- |
- |
051 1件: 51 💬 |
239 |
Overencapsulated mesalazine tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
240 |
Polidocanol |
Polidocanol |
1件: D01993 D01993 💬 |
- |
- |
279 1件: 279 💬 |
241 |
Previously known as r935788 |
- |
- |
- |
- |
046 1件: 46 💬 |
242 |
Previously referred to as medi2070 and amg 139 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
243 |
Previously referred to as medi2070 and amg 139, agn-151-598 |
- |
- |
- |
- |
096 1件: 96 💬 |
244 |
Procedure: assessment of therapy complications |
- |
- |
- |
- |
060 1件: 60 💬 |
245 |
Procedure: autologous hematopoietic stem cell transplantation (asct) |
- |
- |
- |
- |
028 1件: 28 💬 |
246 |
Procedure: bone marrow aspiration |
- |
- |
- |
- |
060 2件: 60, 285 💬 |
247 |
Procedure: ebus guided transbronchial needle aspiration (ebus-tbna) |
- |
- |
- |
- |
084 1件: 84 💬 |
248 |
Procedure: exhaled nitric oxide assessment |
Nitric Oxide |
1件: D00074 D00074 💬 |
- |
- |
046 1件: 46 💬 |
249 |
Procedure: injections upper aspect of trigone of urinary bladder |
- |
- |
- |
- |
226 1件: 226 💬 |
250 |
Procedure: physical exam and updrs part iii assessment |
- |
- |
- |
- |
006 1件: 6 💬 |
251 |
Procedure: pre liver transplantation laparoscopic hand assisted staging |
- |
- |
- |
- |
094 1件: 94 💬 |
252 |
Procedure: quality-of-life assessment |
- |
- |
- |
- |
028 3件: 28, 34, 51 💬 |
253 |
Procedure: quantiferon-tb gold assay |
Gold |
- |
- |
- |
046 1件: 46 💬 |
254 |
Procedure: slit lamp assessment and intra-ocular pressure measurement |
- |
- |
- |
- |
019 1件: 19 💬 |
255 |
Procedure: use of an electronic data capture system by patients and physicians to assess patient-physician interactions & therapeutic decisions & outcomes in ra subjects. |
Bifenthrin |
- |
- |
- |
046 1件: 46 💬 |
256 |
Qol assessment, neuropsychological |
- |
- |
- |
- |
034 1件: 34 💬 |
257 |
Recombinant adeno-associated viral vector expressing the human alpha-1-antitrypsin gene |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 1件: 231 💬 |
258 |
Recombinant adeno-associated viral vector serotype 2.7m8 containing the chrimsonr-tdtomato gene |
- |
- |
- |
- |
090 1件: 90 💬 |
259 |
Recombinant adeno-associated viral vector, serotype 2 (raav2/2) containing the human wild-type mitochondrial nadh dehydrogenase 4 gene (nd4) |
NADH |
- |
- |
- |
302 1件: 302 💬 |
260 |
Recombinant adeno-associated virus 2/6 vector encoding the cdna for human alpha galactosidase a |
- |
- |
- |
- |
019 1件: 19 💬 |
261 |
Recombinant human alpha-galactosidase abbreviated as r-h-alpha-gal |
- |
- |
- |
- |
019 1件: 19 💬 |
262 |
Recombinant human somatotropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 2件: 78, 236 💬 |
263 |
Rectal tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
097 1件: 97 💬 |
264 |
Response to anakinra associated with methotrexate |
Anakinra |
3件: D00142 D00142, D02115 D02115, D02934 D02934 💬 |
DHFR 4件: DHFR, DHFR2, IL1R1, IL1R2 💬 |
Amoebiasis 20件: Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
046 1件: 46 💬 |
265 |
Response to infliximab associated with methotrexate |
Infliximab |
3件: D00142 D00142, D02115 D02115, D02598 D02598 💬 |
DHFR 3件: DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
266 |
Ropinirole (as hydrochloride) |
Ropinirole |
2件: D00784 D00784, D08489 D08489 💬 |
DRD2 3件: DRD2, DRD3, DRD4 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
267 |
Safinamide (as add-on therapy) |
Safinamide |
1件: D10158 D10158 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
268 |
Saizen® solution for injection (referred as saizen®) |
- |
- |
- |
- |
078 1件: 78 💬 |
269 |
Sildenafil (as citrate) |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
270 |
Sildenafil singly or in association with bosentan |
Bosentan |
4件: D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA 3件: EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
271 |
Sin asignar |
- |
- |
- |
- |
299 1件: 299 💬 |
272 |
Sirolimus (formerly known as rapamycin) |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
035 1件: 35 💬 |
273 |
Sodio ascorbato dc.it |
- |
- |
- |
- |
010 1件: 10 💬 |
274 |
Somatotropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
003 3件: 3 , 78, 236 💬 |
275 |
Sorafenib (as tosylate) |
Sorafenib |
2件: D06272 D06272, D08524 D08524 💬 |
BRAF 8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 |
Acute myeloid leukemia 87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway |
034 1件: 34 💬 |
276 |
Spd476 (mesalazine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
277 |
Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
278 |
Sulphsalazine, pentasa, asacol, colazide, depentum |
- |
- |
- |
- |
097 1件: 97 💬 |
279 |
Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil) |
Azathioprine |
8件: D00107 D00107, D00238 D00238, D00752 D00752, D03033 D03033, D05094 D05094, D05095 D05095, D05096 D05096, D08556 D08556 💬 |
IMPDH1 7件: IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 35件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
280 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
281 |
Tacrolimus (advagraf) |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
227 1件: 227 💬 |
282 |
Tacrolimus (prograf®) |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
283 |
Tacrolimus (tacro) |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
065 1件: 65 💬 |
284 |
Tacrolimus and mmf |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
299 1件: 299 💬 |
285 |
Tacrolimus capsule |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
286 |
Tacrolimus capsule (low-dose) |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
227 1件: 227 💬 |
287 |
Tacrolimus capsules |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 2件: 222, 299 💬 |
288 |
Tacrolimus combined with prednisone |
Prednisone |
3件: D00107 D00107, D00473 D00473, D08556 D08556 💬 |
NR3C1 6件: NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 1件: 222 💬 |
289 |
Tacrolimus prolonged-release hard capsules |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
299 1件: 299 💬 |
290 |
Tacrolimus tablets |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
291 |
Tacrolimus with methotrexate |
Methotrexate |
4件: D00107 D00107, D00142 D00142, D02115 D02115, D08556 D08556 💬 |
DHFR 7件: DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
292 |
Tafamidis meglumine 20 mg soft gelatin capsules |
Gelatin |
4件: D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR 1件: TTR 💬 |
Thyroid hormone synthesis 1件: Thyroid hormone synthesis |
028 1件: 28 💬 |
293 |
Tafamidis meglumine 20mg soft gelatin capsule (clinical trial image) |
Gelatin |
4件: D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR 1件: TTR 💬 |
Thyroid hormone synthesis 1件: Thyroid hormone synthesis |
028 1件: 28 💬 |
294 |
Tafamidis meglumine 20mg soft gelatin capsule (commerical image) |
Gelatin |
4件: D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR 1件: TTR 💬 |
Thyroid hormone synthesis 1件: Thyroid hormone synthesis |
028 1件: 28 💬 |
295 |
Terbutaline |
Terbutaline |
2件: D00688 D00688, D08570 D08570 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
118 1件: 118 💬 |
296 |
The investigational medicinal product (imp) may be labelled as either pf-04236921 106 mg/vial, clonal sc lyophilized form” or pf-04236921 powder for injection, 106 mg/vial”. supplies labelled with either nomenclature are equivalent. |
- |
- |
- |
- |
096 1件: 96 💬 |
297 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta |
- |
- |
- |
- |
096 1件: 96 💬 |
298 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta. |
- |
- |
- |
- |
096 1件: 96 💬 |
299 |
Theophylline |
Theophylline |
5件: D00371 D00371, D01712 D01712, D02017 D02017, D06103 D06103, D06104 D06104 💬 |
ADORA1 19件: ADORA1, ADORA2A, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
Alcoholism 24件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
236 2件: 236, 299 💬 |
300 |
Theophylline er |
Theophylline |
5件: D00371 D00371, D01712 D01712, D02017 D02017, D06103 D06103, D06104 D06104 💬 |
ADORA1 19件: ADORA1, ADORA2A, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
Alcoholism 24件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
236 1件: 236 💬 |
301 |
Tildrakizumab |
Tildrakizumab |
1件: D10400 D10400 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
162 2件: 162, 271 💬 |
302 |
Tildrakizumab 100 mg (one 1-ml injection of 100 mg/ml |
Tildrakizumab |
1件: D10400 D10400 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
271 1件: 271 💬 |
303 |
Tildrakizumab 100 mg/ml |
Tildrakizumab |
1件: D10400 D10400 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
271 1件: 271 💬 |
304 |
Tildrakizumab 200 mg (two 1-ml injections of 100 mg/ml) |
Tildrakizumab |
1件: D10400 D10400 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
271 1件: 271 💬 |
305 |
Tildrakizumab prefilled syringe |
Tildrakizumab |
1件: D10400 D10400 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
162 1件: 162 💬 |
306 |
Treatment as usual (tau) |
- |
- |
- |
- |
085 1件: 85 💬 |
307 |
Urinary levels of piiinp as a marker of changes in renal function |
- |
- |
- |
- |
299 1件: 299 💬 |
308 |
Us tap bupivacaine/epinephrine |
Bupivacaine |
5件: D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A 14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
309 |
Vr040/aspirair® inhaler |
- |
- |
- |
- |
006 1件: 6 💬 |